1) Use filters in order to find hits for the screening (drugs which demonstrate similarly enriched paths with MYC-knockdowns)
2) Prioritize final hits using information about the enriched pathways and the rank of myc antivity compared with other
transcription factors
3) Add moa+targets+chemical identifiers from repurposing hub to the initial drug list of cmap
